On this page
Dasha Smith
Insider
First SEC filing: April 5, 2021 · Latest: April 5, 2021
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net: $0
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Oct. 1, 2026 | CNS | A | 375 | · | · | 10,642 Direct | +3.65% | Acquired | (price as of 2026-10-02) |
| July 1, 2026 | CNS | A | 353 | · | · | 10,267 Direct | +3.56% | Acquired | (price as of 2026-10-02) |
| April 1, 2026 | CNS | A | 440 | · | · | 9,914 Direct | +4.64% | Acquired | (price as of 2026-10-02) |
| Jan. 2, 2026 | CNS | A | 436 | · | · | 9,474 Direct | +4.82% | Acquired | (price as of 2026-10-02) |
| Oct. 1, 2025 | CNS | A | 423 | · | · | 9,038 Direct | +4.91% | Acquired | (price as of 2026-10-02) |
| July 1, 2025 | CNS | A | 360 | · | · | 8,615 Direct | +4.36% | Acquired | (price as of 2026-10-02) |
| April 1, 2025 | CNS | A | 341 | · | · | 8,255 Direct | +4.31% | Acquired | (price as of 2026-10-02) |
| Jan. 2, 2025 | CNS | A | 298 | · | · | 7,914 Direct | +3.91% | Acquired | (price as of 2026-10-02) |
| Oct. 1, 2024 | CNS | A | 291 | · | · | 7,616 Direct | +3.97% | Acquired | (price as of 2026-10-02) |
| July 1, 2024 | CNS | A | 383 | · | · | 7,325 Direct | +5.52% | Acquired | (price as of 2026-10-02) |
| April 1, 2024 | CNS | A | 362 | · | · | 6,942 Direct | +5.50% | Acquired | (price as of 2026-10-02) |
| Jan. 2, 2024 | CNS | A | 365 | · | · | 6,580 Direct | +5.87% | Acquired | (price as of 2026-10-02) |
| Oct. 2, 2023 | CNS | A | 442 | · | · | 6,215 Direct | +7.66% | Acquired | (price as of 2026-10-02) |
| July 3, 2023 | CNS | A | 472 | · | · | 5,773 Direct | +8.90% | Acquired | (price as of 2026-10-02) |
| April 3, 2023 | CNS | A | 433 | · | · | 5,301 Direct | +8.89% | Acquired | (price as of 2026-10-02) |
| Jan. 3, 2023 | CNS | A | 419 | · | · | 4,868 Direct | +9.42% | Acquired | (price as of 2026-10-02) |
| Oct. 3, 2022 | CNS | A | 432 | · | · | 4,449 Direct | +10.75% | Acquired | (price as of 2026-10-02) |
| July 1, 2022 | CNS | A | 429 | · | · | 4,017 Direct | +11.96% | Acquired | (price as of 2026-10-02) |
| April 1, 2022 | CNS | A | 315 | · | · | 3,588 Direct | +9.62% | Acquired | (price as of 2026-10-02) |
| Jan. 3, 2022 | CNS | A | 298 | · | · | 3,273 Direct | +10.02% | Acquired | (price as of 2026-10-02) |
| Oct. 1, 2021 | CNS | A | 325 | · | · | 2,975 Direct | +12.26% | Acquired | (price as of 2026-10-02) |
| July 1, 2021 | CNS | A | 304 | · | · | 2,650 Direct | +12.96% | Acquired | (price as of 2026-10-02) |
| April 1, 2021 | CNS | A | 375 | · | · | 2,346 Direct | +19.03% | Acquired | (price as of 2026-10-02) |
| Jan. 4, 2021 | CNS | A | 341 | · | · | 1,971 Direct | +20.92% | Acquired | (price as of 2026-10-02) |
| Oct. 1, 2020 | CNS | A | 447 | · | · | 1,630 Direct | +37.79% | Acquired | (price as of 2026-10-02) |
| July 1, 2020 | CNS | A | 366 | · | · | 1,183 Direct | +44.80% | Acquired | (price as of 2026-10-02) |
| April 1, 2020 | CNS | A | 581 | · | · | 817 Direct | +246.19% | Acquired | (price as of 2026-10-02) |
| Jan. 2, 2020 | CNS | A | 236 | · | · | 236 Direct | · | Acquired | (price as of 2026-10-02) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.